Menstrual dysfunction following use of oral contraceptives.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000568:Amenorrhea / Q000139:chemically induced / Q000188:drug therapy; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008593:Menopause; D008599:Menstruation Disturbances / Q000139:chemically induced* / Q000188:drug therapy; D010060:Ovulation / Q000187:drug effects; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006063:Chorionic Gonadotropin; D003276:Contraceptives, Oral; D006062:Gonadotropins; D002996:Clomiphene